Cataract surgery and nonsteroidal antiinflammatory drugs

Richard S. Hoffman, Rosa Braga-Mele, Kendall Donaldson, Geoffrey Emerick, Bonnie Henderson, Malik Kahook, Nick Mamalis, Kevin M. Miller, Tony Realini, Neal H. Shorstein, Richard K. Stiverson, Barbara Wirostko

Research output: Contribution to journalReview article

24 Citations (Scopus)

Abstract

Nonsteroidal antiinflammatory drugs (NSAIDs) have become an important adjunctive tool for surgeons performing routine and complicated cataract surgery. These medications have been found to reduce pain, prevent intraoperative miosis, modulate postoperative inflammation, and reduce the incidence of cystoid macular edema (CME). Whether used alone, synergistically with steroids, or for specific high-risk eyes prone to the development of CME, the effectiveness of these medications is compelling. This review describes the potential preoperative, intraoperative, and postoperative uses of NSAIDs, including the potency, indications and treatment paradigms and adverse effects and contraindications. A thorough understanding of these issues will help surgeons maximize the therapeutic benefits of these agents and improve surgical outcomes. Financial Disclosure Proprietary or commercial disclosures are listed after the references.

Original languageEnglish (US)
Pages (from-to)1368-1379
Number of pages12
JournalJournal of Cataract and Refractive Surgery
Volume42
Issue number9
DOIs
StatePublished - Sep 1 2016

Fingerprint

Macular Edema
Disclosure
Cataract
Anti-Inflammatory Agents
Miosis
Pharmaceutical Preparations
Steroids
Inflammation
Pain
Incidence
Therapeutics
Surgeons

ASJC Scopus subject areas

  • Surgery
  • Ophthalmology
  • Sensory Systems

Cite this

Hoffman, R. S., Braga-Mele, R., Donaldson, K., Emerick, G., Henderson, B., Kahook, M., ... Wirostko, B. (2016). Cataract surgery and nonsteroidal antiinflammatory drugs. Journal of Cataract and Refractive Surgery, 42(9), 1368-1379. https://doi.org/10.1016/j.jcrs.2016.06.006

Cataract surgery and nonsteroidal antiinflammatory drugs. / Hoffman, Richard S.; Braga-Mele, Rosa; Donaldson, Kendall; Emerick, Geoffrey; Henderson, Bonnie; Kahook, Malik; Mamalis, Nick; Miller, Kevin M.; Realini, Tony; Shorstein, Neal H.; Stiverson, Richard K.; Wirostko, Barbara.

In: Journal of Cataract and Refractive Surgery, Vol. 42, No. 9, 01.09.2016, p. 1368-1379.

Research output: Contribution to journalReview article

Hoffman, RS, Braga-Mele, R, Donaldson, K, Emerick, G, Henderson, B, Kahook, M, Mamalis, N, Miller, KM, Realini, T, Shorstein, NH, Stiverson, RK & Wirostko, B 2016, 'Cataract surgery and nonsteroidal antiinflammatory drugs', Journal of Cataract and Refractive Surgery, vol. 42, no. 9, pp. 1368-1379. https://doi.org/10.1016/j.jcrs.2016.06.006
Hoffman, Richard S. ; Braga-Mele, Rosa ; Donaldson, Kendall ; Emerick, Geoffrey ; Henderson, Bonnie ; Kahook, Malik ; Mamalis, Nick ; Miller, Kevin M. ; Realini, Tony ; Shorstein, Neal H. ; Stiverson, Richard K. ; Wirostko, Barbara. / Cataract surgery and nonsteroidal antiinflammatory drugs. In: Journal of Cataract and Refractive Surgery. 2016 ; Vol. 42, No. 9. pp. 1368-1379.
@article{edbbc9b980dd4a7e80b51bfc9b9250fa,
title = "Cataract surgery and nonsteroidal antiinflammatory drugs",
abstract = "Nonsteroidal antiinflammatory drugs (NSAIDs) have become an important adjunctive tool for surgeons performing routine and complicated cataract surgery. These medications have been found to reduce pain, prevent intraoperative miosis, modulate postoperative inflammation, and reduce the incidence of cystoid macular edema (CME). Whether used alone, synergistically with steroids, or for specific high-risk eyes prone to the development of CME, the effectiveness of these medications is compelling. This review describes the potential preoperative, intraoperative, and postoperative uses of NSAIDs, including the potency, indications and treatment paradigms and adverse effects and contraindications. A thorough understanding of these issues will help surgeons maximize the therapeutic benefits of these agents and improve surgical outcomes. Financial Disclosure Proprietary or commercial disclosures are listed after the references.",
author = "Hoffman, {Richard S.} and Rosa Braga-Mele and Kendall Donaldson and Geoffrey Emerick and Bonnie Henderson and Malik Kahook and Nick Mamalis and Miller, {Kevin M.} and Tony Realini and Shorstein, {Neal H.} and Stiverson, {Richard K.} and Barbara Wirostko",
year = "2016",
month = "9",
day = "1",
doi = "10.1016/j.jcrs.2016.06.006",
language = "English (US)",
volume = "42",
pages = "1368--1379",
journal = "Journal of Cataract and Refractive Surgery",
issn = "0886-3350",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Cataract surgery and nonsteroidal antiinflammatory drugs

AU - Hoffman, Richard S.

AU - Braga-Mele, Rosa

AU - Donaldson, Kendall

AU - Emerick, Geoffrey

AU - Henderson, Bonnie

AU - Kahook, Malik

AU - Mamalis, Nick

AU - Miller, Kevin M.

AU - Realini, Tony

AU - Shorstein, Neal H.

AU - Stiverson, Richard K.

AU - Wirostko, Barbara

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Nonsteroidal antiinflammatory drugs (NSAIDs) have become an important adjunctive tool for surgeons performing routine and complicated cataract surgery. These medications have been found to reduce pain, prevent intraoperative miosis, modulate postoperative inflammation, and reduce the incidence of cystoid macular edema (CME). Whether used alone, synergistically with steroids, or for specific high-risk eyes prone to the development of CME, the effectiveness of these medications is compelling. This review describes the potential preoperative, intraoperative, and postoperative uses of NSAIDs, including the potency, indications and treatment paradigms and adverse effects and contraindications. A thorough understanding of these issues will help surgeons maximize the therapeutic benefits of these agents and improve surgical outcomes. Financial Disclosure Proprietary or commercial disclosures are listed after the references.

AB - Nonsteroidal antiinflammatory drugs (NSAIDs) have become an important adjunctive tool for surgeons performing routine and complicated cataract surgery. These medications have been found to reduce pain, prevent intraoperative miosis, modulate postoperative inflammation, and reduce the incidence of cystoid macular edema (CME). Whether used alone, synergistically with steroids, or for specific high-risk eyes prone to the development of CME, the effectiveness of these medications is compelling. This review describes the potential preoperative, intraoperative, and postoperative uses of NSAIDs, including the potency, indications and treatment paradigms and adverse effects and contraindications. A thorough understanding of these issues will help surgeons maximize the therapeutic benefits of these agents and improve surgical outcomes. Financial Disclosure Proprietary or commercial disclosures are listed after the references.

UR - http://www.scopus.com/inward/record.url?scp=84992397285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992397285&partnerID=8YFLogxK

U2 - 10.1016/j.jcrs.2016.06.006

DO - 10.1016/j.jcrs.2016.06.006

M3 - Review article

C2 - 27697257

AN - SCOPUS:84992397285

VL - 42

SP - 1368

EP - 1379

JO - Journal of Cataract and Refractive Surgery

JF - Journal of Cataract and Refractive Surgery

SN - 0886-3350

IS - 9

ER -